Spoštovani kupci!
Zaradi prenove spletne strani in prehoda na OJS spletna prodaja trenutno ne dela. Prosim, če sporočite, kaj bi radi kupili, na prodaja@medrazgl.si. Dopišite vaše ime in priimek, naslov ter način plačila (s predračunom, ob povzetju ali z gotovino, če prezvamete gradivo v živo v prostorih uredištva v času uradnih ur).
Hvala za razumevanje!
MENU
Anatomy
Anesthesiology
Biochemistry
Biomedical Informatics
Biophysics
Cell Biology
Clinical Cases
Dentistry
Dermatovenerology
Emergency Medicine
Family Medicine
Forensic Medicine
Gynecology and Obstetrics
Histology and Embryology
History of Medicine
Human Genetics
Hygiene
Infectious Diseases
Internal Medicine
Medical Deontology and Philosophy
Medical Psychology
Microbiology and Immunology
Neurology
Occupational Medicine
Oncology
Ophthalmology
Orthopaedics
Otorhinolaryngology
Pathology
Pathophysiology
Pediatrics
Pharmacology and Experimental Toxicology
Physical and Rehabilitation Medicine
Physiology
Psychiatry
Radiology
Social Medicine
Surgery
Toxicology
Research papers
Clinical research paper
Preclinical research paper
Sponsored articles
Archive » 1997 » 4 » | Archive » Medical field » Fields » Gynecology and Obstetrics »

Hormonal screening tests for Down syndrome

 
Abstract:

This post is also available in: English Slovenščina (Slovenian)

Down syndrome is the most common individual cause of mental retardation in children. Prenatal screening for Down syndrome, based on the maternal age, has been practised in Slovenia since 1981. Between 1987 and 1994, Down syndrome was diagnosed prenatally in merely 17% of infants. In 1995, triple-marker testing for the second trimester prenatal diag­nosis of Down syndrome was introduced. Using this method we measured alpha-fetoprotein, human chorionic gonadotrophin and unconju­gated estriol in maternal blood, and estimated the pregnant woman’s risk of carrying a baby with Down syndrome. The expected percentage of detected Down syndrome cases is approxi­mately 60%, with the rate of false positive results being 5 to 7%. The paper describes some practical aspects of the test, and pre­sents pregnancy complications after a false-pos­itive screen for Down syndrome. The paper describes a screening method using ultrasound measurements of fetal nuchal translucency, and new laboratory tests, likely to become useful tools of prenatal diagnosis of Down syndrome in the future.

Authors:
Tul Nataša

Keywords:
Down syndrome alpha-fetoproteins gonadotropins chorionic estriol

Cite as:
Med Razgl. 1997; 36: 523–37.

Download PDF >>
© 2024 Društvo Medicinski razgledi | Na vrh strani / To top ↑